Cargando…
A C1173T Dimorphism in the VKORC1 Gene Determines Coumarin Sensitivity and Bleeding Risk
BACKGROUND: A C1173T polymorphism in intron 1 of the VKORC1 gene has been claimed to determine the interindividual variability in the response to vitamin K antagonist therapy (VKA), but it is unknown whether it also influences bleeding risk. We aimed to confirm the relationship between C1173T status...
Autores principales: | Reitsma, Pieter H, van der Heijden, Jeroen F., Groot, Angelique P, Rosendaal, Frits R, Büller, Harry R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1251635/ https://www.ncbi.nlm.nih.gov/pubmed/16201835 http://dx.doi.org/10.1371/journal.pmed.0020312 |
Ejemplares similares
-
Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With VKORC1 1173C
por: Cho, Eun Hye, et al.
Publicado: (2020) -
Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness
por: Fodor, Daniela, et al.
Publicado: (2013) -
Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists
por: van Heteren, D. Max, et al.
Publicado: (2022) -
G-1639A but Not C1173T VKORC1 Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population
por: Dubovyk, Yevhen I., et al.
Publicado: (2016) -
Height, VKORC1 1173, and CYP2C9 Genotypes Determine Warfarin Dose for Pediatric Patients with Kawasaki Disease in Southwest China
por: Yang, Dan, et al.
Publicado: (2018)